Stonepine Capital Management, LLC Maxcyte, Inc. Transaction History

Stonepine Capital Management, LLC

  • $126 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$3.02 - $5.1 $11.4 Million - $19.2 Million
3,761,640 New
3,761,640 $11.7 Billion
Q2 2023

Aug 11, 2023
BUY
$3.69 - $5.35 $4.65 Million - $6.74 Million
1,259,826 Added 46.54%
3,966,916 $18.2 Million
Q1 2023

May 12, 2023
BUY
$4.03 - $5.89 $9.81 Million - $14.3 Million
2,433,803 Added 890.57%
2,707,090 $13.4 Million
Q4 2022

Feb 14, 2023
BUY
$4.92 - $7.4 $1.34 Million - $2.02 Million
273,287 New
273,287 $1.49 Million

Others Institutions Holding MXCT

# of Institutions
126
Shares Held
62M
Call Options Held
2.4K
Put Options Held
2.1K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $412M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email